Skip to main content
Log in

Clinical Sequelae of Thrombus in an Inferior Vena Cava Filter

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

The purpose of this study was to assess the long-term clinical sequelae of inferior vena cava (IVC) filter thrombus and the effect of anticoagulation on filter thrombus. Of 1,718 patients who had IVC filters placed during 2001–2008, 598 (34.8%) had follow-up abdominal CT. Filter thrombus was seen in 111 of the 598 (18.6%). There were 44 men (39.6%). The mean age at filter placement was 64 years. The medical diseases included cancer in 64, trauma in 15, stroke in 12, and others in 20. The frequency of filter thrombus on CT and asymptomatic filter thrombus on CT was calculated. The frequency of pulmonary embolism (PE) in patients with filter thrombus was calculated. The frequency of thrombus progression or regression (on CT, available in 56) was calculated. The effect of anticoagulation on filter thrombus regression/progression was evaluated using the Fisher exact test by comparing the group of patients who received anticoagulants versus those who did not. A P-value of <0.05 was considered significant. The overall frequency of filter thrombus was 18.6%. Total occlusion of the IVC filter was seen in 12 of 598 (2%). The filter thrombus was asymptomatic in 110 (18.3%). Filter thrombus was detected after a median of 35 days (range, 0–2082) following filter placement. Thrombus extended above the filter in 4 (3.6%); IVC thrombus below the filter was seen in 35(31.5%). Thrombus in the filter occluded <25% of the filter volume in 58 (52.3%), 25–50% in 21 (18.9%), and 50–75% in 20 (18%). Total IVC occlusion was seen in 12 (10.8%). Eighty-three patients received anticoagulation. Sixteen patients developed symptoms of PE. PE was confirmed on CT in 3 of 15 (2.7%). On follow-up, filter thrombus regressed completely in 19 (33.9%) after a median of 6 months. Filter thrombus decreased in size in 13 (23.2%) and it progressed without IVC occlusion in 7 (12.6%). In one (1.7%), filter thrombus progressed to IVC occlusion. Filter thrombus remained stable in 16 (28.6%). There was no significant difference in thrombus regression or progression rates whether or not the patients received anticoagulation for filter thrombus. In conclusion, asymptomatic thrombus in the filter is common and it rarely progresses to complete caval occlusion. Anticoagulation has little effect on the resolution of filter thrombosis and future occurrence of PE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE (2004) Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:401S–428S

    Article  CAS  PubMed  Google Scholar 

  2. Kaufman JA, Kinney TB, Streiff MB et al (2006) Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol 17:449–459

    Article  PubMed  Google Scholar 

  3. PREPIC (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 112:416–422

    Article  Google Scholar 

  4. Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM (2000) Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 216:54–66

    CAS  PubMed  Google Scholar 

  5. Leask RL, Johnston KW, Ojha M (2001) In vitro hemodynamic evaluation of a Simon nitinol vena cava filter: possible explanation of IVC occlusion. J Vasc Interv Radiol 12:613–618

    Article  CAS  PubMed  Google Scholar 

  6. Patel SH, Patel R (2007) Inferior vena cava filters for recurrent thrombosis: current evidence. Tex Heart Inst J 34:187–194

    PubMed  Google Scholar 

  7. Kinney TB (2003) Update on inferior vena cava filters. J Vasc Interv Radiol 14:425–440

    PubMed  Google Scholar 

  8. Kalva SP, Wicky S, Waltman AC, Athanasoulis CA (2006) TrapEase vena cava filter: experience in 751 patients. J Endovasc Ther 13:365–372

    Article  PubMed  Google Scholar 

  9. Tardy B, Mismetti P, Page Y et al (1996) Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases. Eur Respir J 9:2012–2016

    Article  CAS  PubMed  Google Scholar 

  10. David W, Gross WS, Colaiuta E, Gonda R, Osher D, Lanuti S (1999) Pulmonary embolus after vena cava filter placement. Am Surg 65:341–346

    CAS  PubMed  Google Scholar 

  11. Hyers TM, Agnelli G, Hull RD et al (2001) Antithrombotic therapy for venous thromboembolic disease. Chest 119:176S–193S

    Article  CAS  PubMed  Google Scholar 

  12. Jacobs DG, Sing RF (2003) The role of vena caval filters in the management of venous thromboembolism. Am Surg 69:635–642

    PubMed  Google Scholar 

  13. Becker DM, Philbrick JT, Selby JB (1992) Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 152:1985–1994

    Article  CAS  PubMed  Google Scholar 

  14. Joels CS, Sing RF, Heniford BT (2003) Complications of inferior vena cava filters. Am Surg 69:654–659

    PubMed  Google Scholar 

  15. Streiff MB (2000) Vena caval filters: a comprehensive review. Blood 95:3669–3677

    CAS  PubMed  Google Scholar 

  16. Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338:409–415

    Article  CAS  PubMed  Google Scholar 

  17. Greenfield LJ, Proctor MC (1992) Thromboembolism: prevention and treatment with vena cava filters. Semin Arthroplasty 3:123–127

    CAS  PubMed  Google Scholar 

  18. Greenfield LJ, Proctor MC, Cho KJ et al (1994) Extended evaluation of the titanium Greenfield vena caval filter. J Vasc Surg 20:458–464

    CAS  PubMed  Google Scholar 

  19. White RH, Zhou H, Kim J, Romano PS (2001) A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 160:2033–2041

    Article  Google Scholar 

  20. Thomas JH, Cornell KM, Siegel EL, Sparks C, Rosenthal SJ (1998) Vena caval occlusion after bird’s nest filter placement. Am J Surg 176:598–600

    Article  CAS  PubMed  Google Scholar 

  21. Harlal A, Ojha M, Johnston KW (2007) Vena cava filter performance based on hemodynamics and reported thrombosis and pulmonary embolism patterns. J Vasc Interv Radiol 18:103–115

    Article  PubMed  Google Scholar 

  22. Poletti PA, Becker CD, Prina L et al (1998) Long-term results of the Simon nitinol inferior vena cava filter. Eur Radiol 8:289–294

    Article  CAS  PubMed  Google Scholar 

  23. Ray CE, Prochazka A (2008) The need for anticoagulation following inferior vena cava filter placement. Systematic review CardioVasc Interv Radiol 31:316–324

    Article  Google Scholar 

Download references

Acknowledgment

We thank Dr. Athanasoulis for his suggestions and help during the preparation of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjeeva P. Kalva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmad, I., Yeddula, K., Wicky, S. et al. Clinical Sequelae of Thrombus in an Inferior Vena Cava Filter. Cardiovasc Intervent Radiol 33, 285–289 (2010). https://doi.org/10.1007/s00270-009-9664-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-009-9664-x

Keywords

Navigation